Innate Pharma S.A.

IPHA · NASDAQ
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Assets
Cash & Equivalents$53,704$66,396$69,990$70,605
Short-Term Investments$6,323$14,374$21,809$21,851
Receivables$363$1,643$393$46,489
Inventory$0$0$0$0
Other Curr. Assets$2,437$0$13,436$0
Total Curr. Assets$64,978$85,742$111,594$148,012
Property Plant & Equip (Net)$4,955$5,133$5,748$6,322
Goodwill$0$0$0$0
Intangibles$0$0$119$416
Long-Term Investments$10,390$10,281$10,350$9,796
Tax Assets$0$0$9,123$9,006
Other NC Assets$12,614$9,903$14,563$1,635
Total NC Assets$27,959$25,317$39,903$27,175
Other Assets$0$0$0$0
Total Assets$92,937$111,059$151,497$175,187
Liabilities
Payables$4,551$7,923$8,751$8,561
Short-Term Debt$8,470$8,438$8,506$8,451
Tax Payable$0$6,962$6,013$7,021
Deferred Revenue$0$616$0$5,865
Other Curr. Liab.$15,941$7,650$20,544$7,817
Total Curr. Liab.$29,426$32,982$38,224$39,636
LT Debt$17,944$22,182$26,410$30,607
Deferred Rev, NC$0$2,825$0$4,618
Deferred Tax Liab, NC$0$0$0$9,006
Other NC Liab.$40,272$44,132$57,903$39,069
Total NC Liab.$58,367$69,243$84,477$83,650
Other Liabilities$0$0$0$0
Cap. Leases$615$375$587$835
Total Liabilities$87,793$102,225$122,701$123,286
Equity
Pref Stock$0$0$0$0
Common Stock$4,610$4,192$4,049$4,044
Retained Earnings-$407,708-$386,364-$361,657-$336,893
AOCI$1,194$27$355$495
Other Equity$0$0$0$0
Total Equity$5,144$8,834$28,796$51,901
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$92,937$111,059$151,497$184,193
Net Debt-$27,290-$35,776-$35,074-$31,547
Innate Pharma S.A. (IPHA) Financial Statements & Key Stats | AlphaPilot